2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow lusutrombopag: new trials by email Literature Review of lusutrombopag trials Research Report on lusutrombopag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) Lusutrombopag Oral Tablet - Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia | Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 17 | 2024-04-17 | 2025-12-19 |
| An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) Lusutrombopag - Immune Thrombocytopenia | Phase 2 | Terminated | Shionogi | 19 | 2010-04-29 | 2021-02-26 |
| A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP) Placebo, Lusutrombopag - Immune Thrombocytopenia (ITP) | Phase 2 | Terminated | Shionogi | 20 | 2010-03-18 | 2021-03-18 |
Purpura, Thrombocytopenic, Idiopathic (3) · Blood Platelet Disorders (2) · Hematologic Diseases (2) · Purpura, Thrombotic Thrombocytopenic (2) · Thrombocytopenia (2)
Shionogi (2) · Institute of Hematology & Blood Diseases Hospital, China (1)
United States (2) · China (1)
Zhang Lei, MD (1)